SCHEMBL2379110

SCHEMBL2379110

CN(C)C1(c2ccccc2)CCC(=CC(=O)ON2C(=O)CCC2=O)CC1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 18/20 0.49
OPRL1 P41146 17/20 0.49
OPRK1 P41145 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2378581 0.81 OPRM1 (0.53) OPRM1OPRL1OPRK1
Hydrochloric Acid SCHEMBL2378578 0.80 OPRM1 (0.51) OPRM1OPRL1OPRK1
SCHEMBL2781209 0.80 OPRM1 (0.57) OPRM1OPRL1OPRK1
Hydrochloric Acid SCHEMBL2380060 0.78 OPRL1 (0.55) OPRM1OPRL1OPRK1
SCHEMBL17438590 0.78 OPRM1 (0.52) OPRM1OPRL1OPRK1
SCHEMBL303247 0.70 OPRL1 (0.63) OPRM1OPRL1OPRK1
SCHEMBL517752 0.70 OPRL1 (0.69) OPRM1OPRL1OPRK1
Hydrochloric Acid SCHEMBL2379087 0.69 OPRL1 (0.62) OPRM1OPRL1OPRK1
SCHEMBL2378995 0.69 OPRM1 (0.48) OPRM1OPRL1OPRK1
SCHEMBL15356038 0.69 OPRM1 (0.46) OPRM1OPRL1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017630-B2 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2011-09-13 US disclosed
US-20070129347-A1 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129347-A1 Cyclohexylacetic acid compounds ACACA, HCAR2, PCCA OPRM1 3702/4885OPRL1 2478/4885OPRK1 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.